Wird geladen...
Hypomethylation of 111 Probes Predicts Poor Prognosis for Glioblastoma
Glioblastoma (GBM) is a complicated brain tumor with heterogeneous outcome. Identification of effective biomarkers is an urgent need for the treatment decision-making and precise evaluation of prognosis. Based on a relatively large dataset of genome-wide methylation (138 glioblastoma patients), a jo...
Gespeichert in:
| Veröffentlicht in: | Front Neurosci |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Frontiers Media S.A.
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6823878/ https://ncbi.nlm.nih.gov/pubmed/31708732 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnins.2019.01137 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|